Key result
Transcatheter therapies for functional tricuspid regurgitation are emerging as promising alternatives to high-risk surgery, though current clinical data regarding their efficacy and safety remain preliminary and scarce.
Transcatheter therapies for functional tricuspid regurgitation represent a promising, less invasive alternative for high-risk surgical patients, though robust clinical evidence is still needed.
No takes yet. Share an insight, caveat, or question.
May warrant cautious consideration in high-risk patients; leaves open the need for prospective trials to confirm efficacy and safety.
Taramasso et al. (2017) conducted a review in Tricuspid Regurgitation. Transcatheter therapies was evaluated. Transcatheter therapies for functional tricuspid regurgitation are emerging as promising alternatives to high-risk surgery, though current clinical data regarding their efficacy and safety remain preliminary and scarce.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: